Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome.
Phase of Trial: Phase III
Latest Information Update: 04 Jun 2018
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 30 May 2018 Planned primary completion date changed from 10 Aug 2020 to 27 Jul 2020.
- 10 Jun 2017 Biomarkers information updated
- 12 Nov 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.